PMID- 21219698 OWN - NLM STAT- MEDLINE DCOM- 20110418 LR - 20190513 IS - 1945-2403 (Electronic) IS - 0146-4760 (Linking) VI - 35 IP - 1 DP - 2011 Jan TI - Differences in binding affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their deuterated analogues to solid-phase extraction cartridges. PG - 15-22 AB - This study evaluated the potential for partial separation of drugs from their deuterated internal standards using Cerex((R)) Polycrom CLIN II solid-phase extraction (SPE) cartridges. After elution from the column and derivatization, gas chromatography-mass spectrometry results showed that the target compound eluted from the SPE cartridge prior to its deuterated form. This elution separation effect was greater for 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine (MAMP) than for the other drugs studied. When the drugs were eluted in 0.5 mL increments from a 50 mg sorbent bed, no drug appeared in the first fraction. The drug to internal standard ratios (expected value 1.00) for subsequent fractions collected were 1.30, 1.07, and 0.83 for MDA/MDA-d(5); 1.65, 1.18, 0.67, and 0.56 for MDMA/MDMAd(5); and 1.37, 1.18, and 0.95 for MDEA/MDEA-d(6). For d-AMP and d-MAMP, the expected ratio was 0.40. The subsequent ratios were 0.63, 0.46, 0.35, and 0.34 for d-AMP/d-AMP-d(11); and 1.00, 0.59, 0.25, and 0.18 for d-MAMP/d-MAMP-d(14). The affinity of d-MAMPd(14) was shown to be greater than that of d-MAMP-d(5), and deuteration at the propyl end of the molecule was shown to increase binding more than deuteration on the phenyl group. FAU - Romberg, R W AU - Romberg RW AD - Navy Drug Screening Laboratory, 320B B Street, Great Lakes, Illinois, USA. robert.romberg@med.navy.mil FAU - Ntamack, A G AU - Ntamack AG FAU - Blacik, L J AU - Blacik LJ FAU - Kazarian, C M AU - Kazarian CM FAU - Snyder, J Jacob AU - Snyder JJ FAU - Welsh, E R AU - Welsh ER LA - eng PT - Comparative Study PT - Journal Article PL - England TA - J Anal Toxicol JT - Journal of analytical toxicology JID - 7705085 RN - 44RAL3456C (Methamphetamine) RN - 4764-17-4 (3,4-Methylenedioxyamphetamine) RN - AR09D82C7G (Deuterium) RN - CK833KGX7E (Amphetamine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - ML1I4KK67B (3,4-methylenedioxyethamphetamine) SB - IM MH - 3,4-Methylenedioxyamphetamine/*analogs & derivatives/urine MH - Amphetamine/*urine MH - *Deuterium MH - Gas Chromatography-Mass Spectrometry MH - Methamphetamine/*analogs & derivatives/urine MH - N-Methyl-3,4-methylenedioxyamphetamine/*analogs & derivatives/urine MH - Solid Phase Extraction MH - Substance Abuse Detection/methods EDAT- 2011/01/12 06:00 MHDA- 2011/04/19 06:00 CRDT- 2011/01/12 06:00 PHST- 2011/01/12 06:00 [entrez] PHST- 2011/01/12 06:00 [pubmed] PHST- 2011/04/19 06:00 [medline] AID - 10.1093/anatox/35.1.15 [doi] PST - ppublish SO - J Anal Toxicol. 2011 Jan;35(1):15-22. doi: 10.1093/anatox/35.1.15.